• Mon. Aug 15th, 2022

NVAX

  • Home
  • Coronavirus tally: FDA approves Novavax vaccine at time when uptake of shots and boosters is low

Coronavirus tally: FDA approves Novavax vaccine at time when uptake of shots and boosters is low

U.S. health regulators authorized the use of Novavax Inc.’s NVAX, +0.27% COVID-19 vaccine, providing a new option that works differently than the two leading vaccines, but at a time when…